Bifidobacterium longum is a species of small pathogenic bacteria, which naturally occurs in gastrointestinal tracts of human and other animals. The bacterium is added to different types of foods, beverages, and dietary supplements as a probiotic, as it provides many health benefits such as improved digestion and bowel movements.

The growth of the global longum market is driven by increase in demand for probiotic dietary supplements with probiotic ingredients and surge in awareness towards healthy food products. Furthermore, rise in disposable income allows consumers to purchase healthy alternatives to regular food products, which is expected to fuel the growth of the market. However, low level of awareness and meagre purchasing power in underdeveloped countries are anticipated to hinder the market growth.

Market Analysis and Insights: Global Longum Market
The global Longum market is valued at US$ XX million in 2019. The market size will reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026.

Global Longum Scope and Market Size
Longum market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Longum market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
0.2g/Piece
0.25g/Piece

Segment by Application
Medicine
Others

By Company
ATCC Inc
BioGaia AB
Mystic Pharmaceuticals Inc
Hanson Ltd
Biofodan A/S
BioCare Copenhagen ApS
Danisco A/S
Danone SA
Deerland Enzymes Inc

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia